ADAPTIVE BIOTECHNOLOGIES CORPORATION revenue breakdown overview

ADAPTIVE BIOTECHNOLOGIES CORPORATION revenue for the last year amounted to 154.27 M EUR, the most of which — 93.08 M EUR — came from its highest performing source at the moment, Minimal Residual Disease - Service, the year earlier bringing 75.82 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought ADAPTIVE BIOTECHNOLOGIES CORPORATION 154.27 M EUR, and the year before that — 173.14 M EUR.